cefmetazole has been researched along with ganciclovir in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Day, JS; Guan, Y; Guo, Y; Hillgren, KM; Michie, SA; Nishimura, S; Nishimura, T; Peltz, G; Takeda, ST; Wu, M; Xu, D; Yang, Z; Yates, AJ; Zheng, M | 1 |
3 other study(ies) available for cefmetazole and ganciclovir
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Chimeric TK-NOG mice: a predictive model for cholestatic human liver toxicity.
Topics: Animals; Bosentan; Cefmetazole; Chemical and Drug Induced Liver Injury; Cholestasis; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Ganciclovir; Hepatocytes; Humans; Metabolic Clearance Rate; Mice, Transgenic; Species Specificity; Sulfonamides; Thymidine Kinase; Tissue Distribution; Transgenes | 2015 |